U.S. flag

An official website of the United States government

  • not current

NM_003042.4(SLC6A1):c.913G>A (p.Ala305Thr) AND Myoclonic-atonic epilepsy

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Jul 9, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003763931.2

Allele description

NM_003042.4(SLC6A1):c.913G>A (p.Ala305Thr)

Gene:
SLC6A1:solute carrier family 6 member 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p25.3
Genomic location:
Preferred name:
NM_003042.4(SLC6A1):c.913G>A (p.Ala305Thr)
HGVS:
  • NC_000003.12:g.11025836G>A
  • NG_053003.1:g.38108G>A
  • NM_001348250.2:c.913G>A
  • NM_001348251.2:c.553G>A
  • NM_001348252.2:c.379G>A
  • NM_001348253.2:c.379G>A
  • NM_003042.4:c.913G>AMANE SELECT
  • NP_001335179.1:p.Ala305Thr
  • NP_001335180.1:p.Ala185Thr
  • NP_001335181.1:p.Ala127Thr
  • NP_001335182.1:p.Ala127Thr
  • NP_003033.3:p.Ala305Thr
  • NC_000003.11:g.11067522G>A
  • NC_000003.11:g.11067522G>A
  • NM_003042.3:c.913G>A
Protein change:
A127T
Links:
dbSNP: rs1391625316
NCBI 1000 Genomes Browser:
rs1391625316
Molecular consequence:
  • NM_001348250.2:c.913G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001348251.2:c.553G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001348252.2:c.379G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001348253.2:c.379G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_003042.4:c.913G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Myoclonic-atonic epilepsy (MAE)
Identifiers:
MONDO: MONDO:0014633; MedGen: CN231318; Orphanet: 1942; OMIM: 616421

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002125571Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Jul 9, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

SCV005042861Neuberg Centre For Genomic Medicine, NCGM
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significancegermlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Prevalence and architecture of de novo mutations in developmental disorders.

Deciphering Developmental Disorders Study.

Nature. 2017 Feb 23;542(7642):433-438. doi: 10.1038/nature21062. Epub 2017 Jan 25.

PubMed [citation]
PMID:
28135719
PMCID:
PMC6016744

Sex-Based Analysis of De Novo Variants in Neurodevelopmental Disorders.

Turner TN, Wilfert AB, Bakken TE, Bernier RA, Pepper MR, Zhang Z, Torene RI, Retterer K, Eichler EE.

Am J Hum Genet. 2019 Dec 5;105(6):1274-1285. doi: 10.1016/j.ajhg.2019.11.003. Epub 2019 Nov 27.

PubMed [citation]
PMID:
31785789
PMCID:
PMC6904808
See all PubMed Citations (5)

Details of each submission

From Invitae, SCV002125571.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 305 of the SLC6A1 protein (p.Ala305Thr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of SLC6A1-related conditions (PMID: 28135719, 31785789, 34006619). ClinVar contains an entry for this variant (Variation ID: 976158). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SLC6A1 protein function. This variant disrupts the p.Ala305 amino acid residue in SLC6A1. Other variant(s) that disrupt this residue have been determined to be pathogenic (Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Neuberg Centre For Genomic Medicine, NCGM, SCV005042861.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The missense variant c.913G>Ap.Ala305Thr in SLC6A1 gene has been reported previously de novo with Neurodevelopmental Disorders Deciphering Developmental Disorders Study, 2017, Turner et al., 2019. The variant is novel not in any individuals in gnomAD Exomes and 1000 Genomes. This variant has been reported to the ClinVar database as Uncertain Significance/ Likely Pathogenic. The amino acid Alanine at position 305 is changed to a Threonine changing protein sequence and it might alter its composition and physico-chemical properties. The variant is predicted to be damaging by SIFT. The amino acid change p.Ala305Thr in SLC6A1 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 16, 2024